Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals & Petrochemicals | Small Cap
Health Score : 6.01Kronox Lab Sciences, operating in the Chemical & Petrochemicals sector, shows a mixed financial performance. The company demonstrates strong solvency and profitability, driven by high equity and efficient use of capital. Revenue and operating profit have grown significantly, indicating market competitiveness. However, liquidity ratios are poor, suggesting potential challenges in meeting short-term obligations. Financial ratios also present concerns, particularly with low earnings per share and book value. While growth prospects are promising, the company needs to address its liquidity and financial management to ensure long-term stability and success. Future performance will depend on balancing growth with financial prudence.
Health Score : 6.01Kronox Lab Sciences, operating in the Chemical & Petrochemicals sector, shows a mixed financial performance. The company demonstrates strong solvency and profitability, driven by high equity and efficient use of capital. Revenue and operating profit have grown significantly, indicating market competitiveness. However, liquidity ratios are poor, suggesting potential challenges in meeting short-term obligations. Financial ratios also present concerns, particularly with low earnings per share and book value. While growth prospects are promising, the company needs to address its liquidity and financial management to ensure long-term stability and success. Future performance will depend on balancing growth with financial prudence.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
20.34
Industry Median
35.74
Small Cap Median
33.85
P/E RATIO
20.34
P/B RATIO
4.84
Industry Median
2.65
Small Cap Median
2.54
P/S RATIO
5.58
Industry Median
2.40
Small Cap Median
2.03
Others
PEG RATIO
0.00
EV/EBITDA RATIO
13.24
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹151.52 as on Aug 17, 2026.
Growth Score : 8.00The company exhibits strong growth trends, driven by significant increases in revenue, operating profit, and asset base. These positive growth rates indicate a competitive market position and effective business strategies. However, the net income growth rate is low, suggesting potential areas for improvement in profitability. Sustaining these growth rates will be crucial for long-term success. This reflects a dynamic and expanding business environment.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 32.26 | 17.07 | -6.25 | 11.11 | 1 |
| Operating Profit Growth Rate | 33.33 | 10 | 27.27 | 17.86 | 3.03 |
| Earnings Per Share (EPS) Growth | 40.08 | -99.22 | 30.09 | 19.3 | 8.6 |
| Asset Growth Rate | 50 | -5.26 | 37.04 | 33.78 | 29.29 |
| Net Income Growth Rate | 40 | 14.29 | 31.25 | 19.05 | 12 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Plastiblends India Ltd | 8.55 | 13.58 | Highly Undervalued | 53.00 | 14.12 | 37.00 |
| 2 | Vikas Ecotech Ltd | 7.61 | 10.90 | Neutral | 12.00 | 0.02 | 17.00 |
| 3 | Aarti Surfactants Ltd | 7.41 | 44.30 | Undervalued | 47.00 | 14.97 | 12.00 |
| 4 | Diamines & Chemicals Ltd | 7.37 | -18.56 | Neutral | -14.00 | -11.05 | -13.00 |
| 5 | Dynemic Products Ltd | 6.97 | 14.47 | Neutral | 52.00 | 16.33 | 20.00 |
| 6 | Chemcon Speciality Chemicals Ltd | 6.19 | 31.54 | Neutral | 30.00 | 6.44 | 24.00 |
| 7 | Kronox Lab Sciences Ltd | 6.01 | 20.34 | Neutral | 34.00 | 7.45 | 28.00 |
| 8 | HP Adhesives Ltd | 5.19 | 46.89 | Neutral | 13.00 | 0.75 | 7.00 |
| 9 | DIC India Ltd | 3.63 | 24.62 | Neutral | 42.00 | 20.73 | 22.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Kronox Lab Sciences Ltd. is a manufacturer of high-purity specialty fine chemicals used across diverse industries such as pharmaceuticals, agrochemicals, and research. The company offers a wide range of laboratory reagents, pharmaceutical excipients, and specialty chemicals, catering to both domestic and international markets with a focus on quality and precision.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Kronox Lab Sciences Ltd's P/E ratio (TTM) is 20.34, compared to the industry median of 35.74 and large cap median of 33.85.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Kronox Lab Sciences Ltd's P/B ratio is 4.84, compared to the industry median of 2.65 and large cap median of 2.54.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Kronox Lab Sciences Ltd's P/S ratio is 5.58, compared to the industry median of 2.40 and large cap median of 2.03.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Kronox Lab Sciences Ltd's PEG ratio is N/A.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Kronox Lab Sciences Ltd's EV/EBITDA ratio is 13.24.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Kronox Lab Sciences Ltd's ROE is 24.14%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Kronox Lab Sciences Ltd's ROA is 26.56%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Kronox Lab Sciences Ltd's ROCE is 36%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Kronox Lab Sciences Ltd's operating margin is 33.66%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Kronox Lab Sciences Ltd's net margin is 27.72%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Kronox Lab Sciences Ltd's current ratio is 9.25.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Kronox Lab Sciences Ltd's debt-to-equity ratio is 0.01.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Kronox Lab Sciences Ltd's interest coverage ratio is N/A.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Kronox Lab Sciences Ltd's DPS is ₹0.52.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Kronox Lab Sciences Ltd's EPS is 8.60.
(Source line: "Ratios as of 17 Aug 2026, based on last traded price of ₹151.52. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Kronox Lab Sciences Ltd. was incorporated in 2008. Over the years, the company expanded its product portfolio and manufacturing capabilities, establishing itself as a key player in the high-purity chemicals segment. A significant milestone was its successful Initial Public Offering (IPO) in March 2024, listing on both NSE and BSE.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| High Purity Specialty Chemicals | 100% | Operating Profit |
Mr. Anil Kumar Jain (Chairman & Managing Director): A seasoned entrepreneur with extensive experience in the chemical industry, leading the company's strategic vision and growth. Mr. Himanshu Kumar Jain (Whole-time Director): Instrumental in overseeing operations and expanding the company's product lines and market reach. Mr. Ketan Ramani (Whole-time Director): Key in managing the financial and administrative aspects of the company, contributing to its robust operational framework.
No major subsidiaries reported.
Initial Public Offering (IPO) in March 2024.
References
The Kronox Lab Sciences Ltd share price today is ₹151.52 on NSE (KRONOX), as of 18 Aug 2026.
As of 17 Aug 2026, Kronox Lab Sciences Ltd share price is ₹151.52, with previous close ₹N/A. Today's range is ₹N/A to ₹N/A. The 52-week range is ₹N/A to ₹N/A.
As of today, Kronox Lab Sciences Ltd's market cap is ₹563.65 crore (Small Cap).
Kronox Lab Sciences Ltd's current P/E ratio is 20.34, compared to the CHEMICALS & PETROCHEMICALS sector average of 38.
Kronox Lab Sciences Ltd's current P/B ratio is 4.84.
Kronox Lab Sciences Ltd's current dividend yield is 0.34%. Last dividend of ₹0.00 per share was declared on N/A.
Kronox Lab Sciences Ltd's EPS (TTM) is ₹8.60.
Kronox Lab Sciences Ltd. is a manufacturer of high-purity specialty fine chemicals used across diverse industries such as pharmaceuticals, agrochemicals, and research. The company offers a wide range of laboratory reagents, pharmaceutical excipients, and specialty chemicals, catering to both domestic and international markets with a focus on quality and precision.
Kronox Lab Sciences Ltd is promoted by Jain and Ramani Family (Mr. Anil Kumar Jain, Mr. Himanshu Kumar Jain, Mr. Ketan Ramani), holding 74.21% as of 17 Aug 2026.
Kronox Lab Sciences Ltd is listed on NSE (KRONOX) and BSE (544187). Its next quarterly results are expected on July/August 2024 (Q1 FY25).